E-healthcare

E-healthcare

Photo by Shutterstock

E-healthcare
SectorMost major industry classification systems use sources of revenue as their basis for classifying companies into specific sectors, subsectors and industries. In order to group like companies based on their sustainability-related risks and opportunities, SASB created the Sustainable Industry Classification System® (SICS®) and the classification of sectors, subsectors and industries in the SDG Investor Platform is based on SICS.
Health Care
Health Care Providers
Business Model Description

Provide telemedicine and mobilise consultations as well as digital emergency response systems to rural communities

Expected Impact

Provide cost-effective access to healthcare services for remote communities.

Indicative ReturnDescribes the rate of growth an investment is expected to generate within the IOA. The indicative return is identified for the IOA by establishing its Internal Rate of Return (IRR), Return of Investment (ROI) or Gross Profit Margin (GPM).
20% - 25% (in ROI)
Investment TimeframeDescribes the time period in which the IOA will pay-back the invested resources. The estimate is based on asset expected lifetime as the IOA will start generating accumulated positive cash-flows.
Short Term (0–5 years)
Market SizeDescribes the value of potential addressable market of the IOA. The market size is identified for the IOA by establishing the value in USD, identifying the Compound Annual Growth Rate (CAGR) or providing a numeric unit critical to the IOA.
< USD 50 million
Direct ImpactDescribes the primary SDG(s) the IOA addresses.
Good health and well-being (SDG 3) Gender Equality (SDG 5)
Indirect ImpactDescribes the secondary SDG(s) the IOA addresses.
Decent Work and Economic Growth (SDG 8) Industry, Innovation and Infrastructure (SDG 9) Reduced Inequalities (SDG 10)
Sector Sources
  • (1) Sachs, J., Schmidt-Traub, G., Kroll, C., Lafortune, G., Fuller, G., Woelm, F. 2020. The Sustainable Development Goals and COVID-19. Sustainable Development Report 2020. Cambridge: Cambridge University Press. (2) UN Office for the Coordination of Humanitarian Affairs (2020). West And Central Africa COVID-19 Digest, 26 July. https://reports.unocha.org/en/country/west-central-africa/card/6uLx4i1qIe/ (3) World Bank database. https://data.worldbank.org/ (4) Ghana Ministry of Health (2020). National Health Policy: Ensuring healthy lives for all. (4a) MedCOI (2019). Country policy and information note Ghana: medical and healthcare issues. UK Government. (4b) UN Development Programme (2019). Inequalities in Human Development in the 21st Century. Briefing note for countries on the 2019 Human Development Report. (5) Conceição, P. (2019). Human Development Report 2019: Beyond income, beyond averages, beyond today: Inequalities in human development in the 21st century. UNDP, New York. (6) World Health Organization (2018). The 2018 update: Global Health Workforce Statistics. Geneva. http://www.who.int/hrh/statistics/hwfstats/ (7) Masibo, R., Kiarie, H. and Bartilol, P. Policy brief: human resources for health – gaps and opportunities for strengthening. Kenya Ministry of Health. (8) Ghana Health Service (2017). Ghana Health Service Annual Report 2016. https://www.ghanahealthservice.org/downloads/GHS_ANNUAL_REPORT_2016_n.pdf (9) Medium-Term National Development Policy Framework: An Agenda for Jobs: Creating Prosperity and Equal Opportunity for All (First Step) 2018-2021. (10) Ghana Investment Promotion Centre (2017). Doing business in Ghana – to know and invest in Ghana. (11) Ministry of Health (2014). Health Sector Medium Term Development Plan 2014-2017. (12) Council on Foreign Relations (2016). Violence against Women in Ghana: Unsafe in the Second Safest Country in Africa. https://www.cfr.org/blog/violence-against-women-ghana-unsafe-second-safest-country-africa
IOA Sources
  • (I) Ghana Health Service (2018). The Health Sector in Ghana: Facts and Figures. (II) Ghana Telemedicine Program. https://globalhealthprogress.org/collaboration/ghana-telemedicine-program/ (III) Barbor, M. (2018). Building Improved and Sustainable Health-Care Systems Through Telemedicine. https://ascopost.com/issues/november-25-2018/building-improved-and-sustainable-health-care-systems-through-telemedicine/ (IV) GSMA (2020).The state of mobile in Ghana’s tech ecosystem. https://www.gsma.com/mobilefordevelopment/blog/the-state-of-mobile-in-ghanas-tech-ecosystem/#:~:text=There%20are%2013.1%20million%20active,million%20registered)%20mobile%20money%20accounts.&text=As%20of%20the%20third%20quarter,(as%20of%20Q3%202019) (V) GSMA (2014). Mobile for Development - mHealth Country Feasibility (Ghana). https://www.gsma.com/mobilefordevelopment/wp-content/uploads/2014/12/mHealth_Country_Feasibility_Report_Ghana_20141.pdf (VI) Novartis. Ghana Telemedicine Toolkit: Interactive Implementation Guide. https://www.novartisfoundation.org/sites/www.novartisfoundation.org/files/Interactive%20Implementation%20Guide.pdf (VII) Drury, P., Roth, S., Jones, T., Stahl, M. and Medeiros, D. (2018). Guidance for Investing in Digital Health. Asian Development Bank. https://www.adb.org/sites/default/files/publication/424311/sdwp-052-guidance-investing-digital-health.pdf (VIII) Osten, B. (2016). Cost-Effectiveness Analysis Of Telemedicine For Primary Healthcare In Amansie-West District. Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., http://ir.knust.edu.gh/bitstream/123456789/9964/1/Final%20Project.pdf (X) Ogoe, H.A., Asamani, J.A., Hochheiser, H. et al. (2018). ‘Assessing Ghana’s eHealth workforce: implications for planning and training’. Human Resources for Health 16(65). (XI) PwC analysis based on Prof. A. Damodaran data, 2020. (X) Technology Advice (2015). Do Patients Trust Telemedicine? - 2015 Trends in Virtual Healthcare Services. http://telecareaware.com/wp-content/uploads/2015/07/technologyadvice-telemedicine-study-T46.pdf (XI) BMC Medical Informatics and Decision Making (2020). Lessening barriers to healthcare in rural Ghana: providers and users’ perspectives on the role of mHealth technology. A qualitative exploration. https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-020-1040-4